跳到正文
Swissmedic 药品质量与 GMP 更新·· 21 天前精选AI 评分60

Swissmedic 自 2026 年 11 月 1 日起重大变更通报仅通过 SMC Portal 提交

Submission of notifications of major changes via the Swissmedic Portal from 1 November 2026

AI 导读

Swissmedic 自 2026 年 11 月 1 日起要求重大变更通报只能通过 SMC Portal 提交。该流程已于 2026 年 9 月 24 日迁至 SMC Portal,此前仍可通过 MLP Portal 提交;到 2026 年 10 月 31 日为止,还可通过 eGov 服务“Licences – major changes”提交。

推荐理由

材料说明重大变更通报渠道切换的生效日期与提交前提,便于持证企业核对系统权限和许可证状态。

正文 · 原文

Submission of notifications of major changes via the Swissmedic Portal from 1 November 2026

(major changes according to Article 41 paragraph 2 MPLO)

02.11.2026

As announced, the process for notification of major changes was transferred to the new Swissmedic Portal (SMC Portal) with effect from 24 September 2026. However, until now it was still possible to submit a notification via the MLP Portal. From 1 November 2026, notifications of major changes must be submitted exclusively via the SMC Portal.

The Medicinal Products Licensing Ordinance (MPLO; Article 41 paragraph 2) requires establishment licence holders to notify Swissmedic of major changes to facilities, equipment, systems and processes (see also Technical Interpretation I-SMI.TI.22e). Until 31 October 2026, these notifications could be submitted via the eGov service “Licences – major changes”. From 1 November 2026, only the SMC Portal can be used.

Requirements:

The following requirements must be met to submit notifications of major changes:

If you have questions regarding the new process, please contact

inspectorates@swissmedic.ch

来源:Swissmedic 药品质量与 GMP 更新 · swissmedic.ch

所属事件

查看事件全部
Swissmedic变更通报:SMC Portal与AI系统